| Penni Young Garland, RNC, ARNP | |
|
1101 S Belmont Ave, Ste. 105, Okmulgee, OK 74447-6315 | |
| (918) 756-2533 | |
| (918) 756-9588 |
| Full Name | Penni Young Garland |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner - Obstetrics & Gynecology |
| Location | 1101 S Belmont Ave, Okmulgee, Oklahoma |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1245294016 | NPI | - | NPPES |
| 200053850A | Medicaid | OK |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LX0001X | Nurse Practitioner - Obstetrics & Gynecology | R0076634 (Oklahoma) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Penni Young Garland, RNC, ARNP 1101 S Belmont Ave, Ste. 105, Okmulgee, OK 74447-6315 Ph: (918) 756-2533 | Penni Young Garland, RNC, ARNP 1101 S Belmont Ave, Ste. 105, Okmulgee, OK 74447-6315 Ph: (918) 756-2533 |
News Archive
A team of researchers from leading universities in Turkey and the United States have reported that they have identified the genetic mutation responsible for the Uner Tan Syndrome (UTS) using advanced genetic capture and sequencing technologies from Roche. The combined genomic technologies enabled the team of scientists to identify the causative mutation of this debilitating disease after years of mystery.
Roper Industries, Inc. today announced that it has completed the previously announced acquisition of Northern Digital, Inc., a leading provider of 3-D measurement technology for medical applications.
Lotus Pharmaceuticals, Inc., a growing developer, manufacturer and seller of medicine and drugs in the People's Republic of China today reported that its innovative asthma drug Laevo-Bambuterol has received approval from China's State Food & Drug Administration's (SFDA) to commence clinical trials (No.2010L01309 and 2010L01399).
A researcher at the Indiana University Melvin and Bren Simon Comprehensive Cancer Center has been awarded a five-year, $5.7 million National Cancer Institute grant to evaluate long-term health outcomes for cancer patients who receive platinum-based chemotherapies.
Soligenix, Inc., a clinical stage biopharmaceutical company focused on developing products to treat inflammatory diseases and biodefense countermeasures where there remains an unmet medical need, announced today that it has initiated the first clinical study for development of SGX203 (oral beclomethasone 17,21-dipropionate or oral BDP) for the treatment of pediatric Crohn's disease.
› Verified 7 days ago
Jearlyn Kay Nick, ARNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 1151 S Belmont Ave, Suite 101, Okmulgee, OK 74447 Phone: 918-759-2200 Fax: 918-759-2206 | |
Amanda Lynne Doane, FNP-C Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1313 E 20th St, Okmulgee, OK 74447 Phone: 918-591-5700 | |
Stephanie M Moses, APRN-CNP, AGACNP-BC Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1401 Dr R Alexander Dr., Okmulgee, OK 74447 Phone: 918-756-4233 | |
Shawn Lynn Howell, APRN, FNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 15495 N 247 Rd, Okmulgee, OK 74447 Phone: 918-733-1351 | |
Teri M Garner, A.R.N.P. Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 1313 E 20th St, Okmulgee, OK 74447 Phone: 918-758-2717 Fax: 918-756-4490 | |
Lacy Garrison, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 111 S Alabama Ave, Okmulgee, OK 74447 Phone: 918-756-2800 |